Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arbaclofen in Children and Adolescents With Autism Spectrum Disorders
NCT07655115Phase 3Recruiting
- Sponsor
- Gregorio Marañón University General Hospital
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Countries
- 2
01
Overview
A Phase 3 trial of arbaclofen in Autism Spectrum Disorder (ASD), sponsored by Gregorio Marañón University General Hospital. Started Nov 2025; status: recruiting.
02
Drugs
arbaclofen
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT07655115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07655115.